Ciglitazone-induced cellular anti-proliferation increases p27kip1 protein levels through both increased transcriptional activity and inhibition of proteasome degradation
- 31 July 2005
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 17 (7) , 809-816
- https://doi.org/10.1016/j.cellsig.2004.11.002
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01-CA93741)
This publication has 21 references indexed in Scilit:
- Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF‐κβJournal of Cellular Biochemistry, 2003
- 15-Lipoxygenase-1 Metabolites Down-regulate Peroxisome Proliferator-activated Receptor γ via the MAPK Signaling PathwayJournal of Biological Chemistry, 2001
- Roles of PPARs in health and diseaseNature, 2000
- SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27Nature Cell Biology, 1999
- CDK inhibitors: positive and negative regulators of G1-phase progressionGenes & Development, 1999
- Peroxisome proliterator-activated receptors, orphans with ligands and functionsCurrent Opinion in Lipidology, 1997
- Translational Control of p27 Kip1 Accumulation During the Cell CycleScience, 1996
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994